Baker Brothers Advisors LLC
29
47M
16
1.26
4
0.45
13
- Stages of investment
- Areas of investment
Summary
The main department of described VC is located in the New York. The fund was located in North America if to be more exact in United States.
The overall number of key employees were 1.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Baker Brothers Advisors LLC, startups are often financed by New Leaf Venture Partners, Alta Partners, Sofinnova Investments. The meaningful sponsors for the fund in investment in the same round are Ventures West, New Leaf Venture Partners, Sofinnova Investments. In the next rounds fund is usually obtained by New Leaf Venture Partners, Redmile Group, Yasuda Enterprise Development.
The important activity for fund was in 2007. Comparing to the other companies, this Baker Brothers Advisors LLC performs on 14 percentage points more the average number of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations. The top amount of exits for fund were in 2019. The fund is constantly included in less than 2 deals per year.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Health Diagnostics. The fund has exact preference in some founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Synageva BioPharma, diaDexus, MethylGene
Investments analytics
Analytics
- Total investments
- 29
- Lead investments
- 4
- Exits
- 13
- Rounds per year
- 1.26
- Follow on index
- 0.45
- Investments by industry
- Biotechnology (28)
- Therapeutics (15)
- Health Care (11)
- Pharmaceutical (10)
- Medical (9) Show 7 more
- Investments by region
-
- United States (17)
- Bermuda (3)
- France (1)
- Canada (5)
- Austria (2)
- Peak activity year
- 2007
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Avg. valuation at time of investment
- 531M
- Group Appearance index
- 0.93
- Avg. company exit year
- 14
- Avg. multiplicator
- 9.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals | 01 Feb 2018 | Biotechnology, Medical, Biopharma | Late Stage Venture | 200M | Devonshire, Bermuda, Bermuda |
| Phenomix | 08 Mar 2007 | Biotechnology, Health Care, Pharmaceutical | Late Stage Venture | 55M | United States, California, San Diego |
| Qinheli Biomedical | 16 Jul 2019 | Health Care, Medical | Seed | 9M | Shanghai, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.